Complications of corticosteroid and immunosuppressive drugs.
Rubin
B
B
National Eye Institute, Bethesda, MD 20892.
Palestine
A G
AG
D000284:Administration, Oral; D000287:Administration, Topical; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000009:adverse effects*; D000477:Alkylating Agents / Q000009:adverse effects; D000963:Antimetabolites / Q000009:adverse effects; D002386:Cataract / Q000139:chemically induced; D065306:Corneal Injuries; D003524:Cyclosporins / Q000008:administration & dosage / Q000009:adverse effects; D003875:Drug Eruptions / Q000209:etiology; D004347:Drug Interactions; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007267:Injections / Q000009:adverse effects; D007275:Injections, Intravenous; D007429:Intraocular Pressure / Q000187:drug effects; D007674:Kidney Diseases / Q000139:chemically induced; D010024:Osteoporosis / Q000139:chemically induced; D010913:Pituitary-Adrenal System / Q000187:drug effects; D014945:Wound Healing / Q000187:drug effects
D000305:Adrenal Cortex Hormones; D000477:Alkylating Agents; D000963:Antimetabolites; D003524:Cyclosporins; D007166:Immunosuppressive Agents